CurrentColorado Rocky Mountain Health PlansPolicy 2026R6005A

CMS-1500 drug testing reimbursement (presumptive, definitive, specimen validity)

Defines reimbursement rules for presumptive and definitive drug testing and specimen validity testing billed on the CMS-1500 form for UnitedHealthcare Commercial and Individual Exchange products; applies to all providers billing those forms.

Policy Summary

PayerColorado Rocky Mountain Health Plans

PolicyCMS-1500 drug testing reimbursement (presumptive, definitive, specimen validity)

Policy CodePolicy 2026R6005A

Change TypeNon-material code list updates

Effective Date

Next Review Date

Key ActionDeny specimen validity testing when performed on the same date as presumptive and/or definitive drug testing unless documentation and an appropriate modifier justify separate reimbursement.

SourceLink

POLICY UPDATE CHANGES

Definitive Drug Testing Codes list updated (policy version changes noted on 9/21/2025 or 10/12/2025 and 9/22/2024).

onepresumptive drug test allowed per patient per date of service

onedefinitive drug test allowed per patient per date of service

includedSpecimen Validity Testing included in presumptive/definitive codes (not separately reimbursable)

CMS-1500Form applicability

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria

Coverage Criteria — Reimbursement rules per date of service and code definitions

Reimbursement rules per date of service and code definitions.

UnitedHealthcare will reimburse drug testing services billed on the CMS-1500 form for UnitedHealthcare Commercial and Individual Exchange products only when the criteria below are met.

ALL of the following

Presumptive drug testing codes represent all tests by methodology per date of service and should be reported once per patient per date of service; UnitedHealthcare will reimburse only one presumptive drug test per patient per date of service.
Presumptive drug testing codes include CPT 80305, 80306, 80307 and H0003; per CPT guidelines each presumptive code represents a single per-patient service irrespective of number of Drug Class procedures or results on that date of service.

ALL of the following

Definitive drug testing identifies specific drugs/metabolites and is qualitative or quantitative; UnitedHealthcare will reimburse only one definitive drug test per patient per date of service.
Consistent with CMS, CPT definitive drug testing codes 80320-80377 are considered non-reimbursable; report HCPCS G0480-G0483 or G0659 for definitive testing when applicable. Proprietary Laboratory Analysis (PLA) CPT codes may be reported and are considered under the definitive testing guidelines.

ALL of the following

Specimen Validity Testing (to assure a specimen has not been compromised or adulterated) is considered included in the presumptive and definitive drug testing CPT and HCPCS code descriptions as quality control and is not separately reimbursable when performed on the same date of service by the same or a different provider.
UnitedHealthcare will deny Specimen Validity Testing when performed on the same date of service as a presumptive and/or definitive drug test by the same or different provider.

Modifier exception

A modifier may permit separate reimbursement when a service commonly used for Specimen Validity Testing is performed distinctly separate from the drug test service and documentation supports that the laboratory service was not related to drug testing (records must support the service was not for Specimen Validity Testing and the modifier was appropriately reported).
UnitedHealthcare will consider separate reimbursement for other laboratory services performed the same day (for example, urinalysis for urinary tract infection) only when an appropriate modifier is appended and documentation supports the service was distinct from specimen validity or drug testing; refer to the Modifier Reference Policy for additional guidance.

UnitedHealthcare will not reimburse more than one presumptive and/or one definitive drug test per patient per date of service regardless of the number of billing providers.

Drug testing services determined to be court-ordered and/or funded by a county, state or federal agency will be denied to healthcare professionals in accordance with the Services and Modifiers Not Reimbursable policy.

Coding and Limits

Presumptive Drug Testing (Covered)mixedCovered

80305	Drug test, presumptive; any number of drug classes
80306	Drug test, presumptive; definitive confirmation not performed (if applicable)
80307	Drug test, presumptive; multiple drug classes (method-based)
H0003	Alcohol and/or drug screening

Definitive Drug Testing (Covered HCPCS/PLA)mixedCovered

G0480	Drug screen, definitive, each number of drug classes (per day service)
G0481	Drug screen, definitive (level II)
G0482	Drug screen, definitive (level III)
G0483	Drug screen, definitive (level IV)
G0659	Drug screen, definitive, multiple drug classes (per day)
0007U	PLA/Proprietary laboratory analysis - specific definitive test
0011U	PLA code (related mapping)
0082U	PLA code (related mapping)
0328U	PLA code (related mapping)
0517U	PLA code (series)

1–10 of 14

1/2

Specimen Validity & Other Lab CodesmixedCovered

83516	Specimen validity testing / urine drug testing component
83518	Specimen validity testing component
83519	Specimen validity testing component
83520	General urine drug testing component (mapped)
83789	Other drug screen analyte (mapped)

Provider Actions & Billing Guidance

Denial Risk

Denial risk — Specimen validity testing billed same day as drug test

UnitedHealthcare will deny specimen validity testing when it is performed on the same date of service as a presumptive and/or definitive drug test by the same or a different provider. A modifier may be appropriate only when the specimen validity–type service is performed distinctly separate from the drug test and documentation supports that the service was not related to drug testing.

Specimen validity testing is considered included in presumptive and definitive drug testing code descriptions and is not separately reimbursable when performed the same day as the drug test.
If billing separately, append an appropriate modifier and retain documentation that the laboratory service was distinct from specimen validity testing and unrelated to the drug test.

Definitions

Drug Class

DefinitionDrug Class: A group of drugs that have the same chemical structure, work in the same way and/or are used for the same purpose.

Use in testingPresumptive drug testing (screening) determines the presence or absence of drugs or a Drug Class; results are reported as negative or positive.

Coding implicationPer CPT guidelines, each presumptive drug testing code represents all drug and Drug Class tests by that methodology per date of service.

Proprietary Laboratory Analysis (PLA) Codes

DefinitionProprietary Laboratory Analysis (PLA) Codes: Describe proprietary clinical laboratory analyses that may be provided by a single ('sole‑source') laboratory or marketed to multiple laboratories and can include ADLTs and CDLTs as defined under PAMA.

Scope